Safety and activity of ibrutinib plus rituxima... - CLL Support

CLL Support

22,532 members38,709 posts

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukemia: a single-arm, phase 2 study

shazie profile image
0 Replies

I am not sure if you need to pay to view the whole article.

This article can be found in the following collections: Oncology (Haematological cancer)

Published Online: 21 August 2014

thelancet.com/journals/lano...

Written by
shazie profile image
shazie
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE)

here: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30433-6/fulltext Jackie

BTK C481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Woyach. http://ascopubs.org/doi/pdf/10.1200/JCO.2016.70.2282 will give you access to the whole...

Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for patients needing treatment after a targeted therapy...

Encouraging results from venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

progressing.)...

Neem extract nimbolide

Just found about it, does anybody tried it ? https://www.nature.com/articles/bcj201474...